Roche
2023
The pharmaceutical industry is one of Germany’s most important export industries. In recent years, the export of pharmaceutical products has seen above-average growth compared to the other export sectors. In addition, research and development play a prominent role for pharmaceutical companies.
Our new study for Roche focuses on these two aspects. It examines the extent to which the German pharmaceutical industry is particularly value-added intensive and innovative in its exports.
Compared to those in the other industries, German pharmaceutical exports are characterised by above-average value-added intensity and growth dynamics. This means that the export of pharmaceutical products (for example, worth one million euros) is linked to more domestic value added and jobs than the average German export of one million euros.
In an international comparison, the German pharmaceutical industry is shown to be one of the most important players on the world market and has been able to maintain its share of world exports in recent years.
In terms of research, the German pharmaceutical industry is losing ground on its international competitors:
For this detailed investigation of the German pharmaceutical industry in a national and international comparison, we relied on the available statistical data. This was then analysed with the help of the Prognos model landscape.
To the study (PDF in German)
Further information, in German (Roche website)
Project team: Dr Georg Klose, Dr Andreas Sachs, Johann Weiss
Latest update: 07.12.2023
Senior Project Manager
A race to catch up - this is what Europe needs if it is not to be left behind by the USA and China. In the SPIEGEL guest article, Christian Böllhoff calls for a new match plan with clear priorities for the new EU legislative period.
In uncertain times, there is a growing demand for orientation. PEO® delivers independent figures. Based on our wolrd economy model we project the developments until 2045.
Growth in the German economy benefits the whole of Europe. Our study for the vbw shows that this is due to the size of the economy and its strong foreign trade networks.
Employees want tailor-made reconciliation measures that ensure work-life balance and not to face professional disadvantage as a result of their care work. These were the findings of our study for the BMFSFJ.
Which companies are already using or developing artificial intelligence? Which companies would benefit from the use of AI? Prognos created an interactive dashboard for one federal state.
Prognos develops a tool for an industry association that enables member companies to carry out risk analyses to identify sustainability risks in countries and sectors.
We have produced guidelines for successful sustainability reporting in accordance with the Corporate Sustainability Reporting Directive for an industry association. The third guide deals with data management in accordance with the CSRD.
We have produced guidelines for successful sustainability reporting in accordance with the Corporate Sustainability Reporting Directive for an industry association. The second guide is dedicated to the topic of "Sustainability Governance".
The study for the European Commission examines the impact of digitalisation on the employment situation in the individual member states as well as on the EU economy as a whole.
In his guest article "Move Europe - it's urgent!" in WirtschaftsWoche, Christian Böllhoff calls for Europe to reposition itself geo-economically in order to strengthen its position between the economic giants USA and China.
Prognos is one of the oldest economic research centres in Europe. Founded at the University of Basel, Prognos experts have been conducting research for a wide range of clients from the public and private sectors since 1959 – politically independent, scientifically sound.